- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabidiol modulation of hippocampal glutamate in early psychosis
Authors
Keywords
-
Journal
JOURNAL OF PSYCHOPHARMACOLOGY
Volume -, Issue -, Pages 026988112110011
Publisher
SAGE Publications
Online
2021-04-16
DOI
10.1177/02698811211001107
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New Evidence Supporting a Role of Hippocampus in the Development of Psychosis
- (2020) Hengyi Cao et al. BIOLOGICAL PSYCHIATRY
- Hippocampal glutamate and hippocampus subfield volumes in antipsychotic-naive first episode psychosis subjects and relationships to duration of untreated psychosis
- (2020) Frédéric Briend et al. Translational Psychiatry
- Effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder
- (2019) Charlotte Marie Pretzsch et al. NEUROPSYCHOPHARMACOLOGY
- Hyperactivity and Reduced Activation of Anterior Hippocampus in Early Psychosis
- (2019) Maureen McHugo et al. AMERICAN JOURNAL OF PSYCHIATRY
- Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention
- (2018) J A Lieberman et al. MOLECULAR PSYCHIATRY
- Magnetic Resonance Spectroscopy in Schizophrenia: Evidence for Glutamatergic Dysfunction and Impaired Energy Metabolism
- (2018) João M. N. Duarte et al. NEUROCHEMICAL RESEARCH
- Neurometabolite levels in antipsychotic-naïve/free patients with schizophrenia: A systematic review and meta-analysis of 1 H-MRS studies
- (2018) Yusuke Iwata et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial
- (2018) Douglas L. Boggs et al. PSYCHOPHARMACOLOGY
- Hippocampal glutamate metabolites and glial activation in clinical high risk and first episode psychosis
- (2018) Shima Shakory et al. NEUROPSYCHOPHARMACOLOGY
- Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis
- (2018) Sagnik Bhattacharyya et al. JAMA Psychiatry
- Association of Hippocampal Glutamate Levels With Adverse Outcomes in Individuals at Clinical High Risk for Psychosis
- (2018) Matthijs G. Bossong et al. JAMA Psychiatry
- Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal information
- (2017) Mohini Ranganathan et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Hippocampal Subregions Across the Psychosis Spectrum
- (2017) Teresa Vargas et al. SCHIZOPHRENIA BULLETIN
- Resting Hyperperfusion of the Hippocampus, Midbrain, and Basal Ganglia in People at High Risk for Psychosis
- (2016) Paul Allen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Therapeutic Potential of Cannabinoids in Psychosis
- (2016) F. Markus Leweke et al. BIOLOGICAL PSYCHIATRY
- Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors
- (2016) Raquel Linge et al. NEUROPHARMACOLOGY
- Cannabidiol, neuroprotection and neuropsychiatric disorders
- (2016) Alline C. Campos et al. PHARMACOLOGICAL RESEARCH
- Targeting glutamate to treat schizophrenia: lessons from recent clinical studies
- (2016) Katherine Beck et al. PSYCHOPHARMACOLOGY
- Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A 1H MRS Study at 7Tesla
- (2016) Allison S. Brandt et al. SCHIZOPHRENIA RESEARCH
- Nature of Glutamate Alterations in Schizophrenia
- (2016) Kate Merritt et al. JAMA Psychiatry
- Association Between Continued Cannabis Use and Risk of Relapse in First-Episode Psychosis
- (2016) Tabea Schoeler et al. JAMA Psychiatry
- Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose
- (2016) P Seeman Translational Psychiatry
- Glutamate and dopamine in schizophrenia: An update for the 21st century
- (2015) Oliver Howes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol, a Cannabis sativa constituent, inhibits cocaine-induced seizures in mice: Possible role of the mTOR pathway and reduction in glutamate release
- (2015) Pedro H. Gobira et al. NEUROTOXICOLOGY
- Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids
- (2015) E. Appiah-Kusi et al. PSYCHOLOGICAL MEDICINE
- Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- (2014) Orrin Devinsky et al. EPILEPSIA
- Relationship Between Brain Glutamate Levels and Clinical Outcome in Individuals at Ultra High Risk of Psychosis
- (2014) Alice Egerton et al. NEUROPSYCHOPHARMACOLOGY
- Cannabinoid Modulation of Functional Connectivity within Regions Processing Attentional Salience
- (2014) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
- Role of the endocannabinoid system in brain functions relevant for schizophrenia: An overview of human challenge studies with cannabis or ∆9-tetrahydrocannabinol (THC)
- (2014) Matthijs G. Bossong et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia
- (2014) Pilar Sánchez-Blázquez et al. Frontiers in Pharmacology
- Metabolic alterations associated with schizophrenia: a critical evaluation of proton magnetic resonance spectroscopy studies
- (2013) Anne Schwerk et al. JOURNAL OF NEUROCHEMISTRY
- Imaging Patients with Psychosis and a Mouse Model Establishes a Spreading Pattern of Hippocampal Dysfunction and Implicates Glutamate as a Driver
- (2013) Scott A. Schobel et al. NEURON
- Quantification of endocannabinoids in postmortem brain of schizophrenic subjects
- (2013) Carolina Muguruza et al. SCHIZOPHRENIA RESEARCH
- Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis
- (2013) Kate Merritt et al. Frontiers in Psychiatry
- Induction of Psychosis byΔ9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience Processing
- (2012) Sagnik Bhattacharyya ARCHIVES OF GENERAL PSYCHIATRY
- Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
- (2012) Amir Englund et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of δ-9-tetrahydrocannabinol on midbrain and striatal function
- (2012) S Bhattacharyya et al. MOLECULAR PSYCHIATRY
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Effects of Δ9-Tetrahydrocannabinol Administration on Human Encoding and Recall Memory Function: A Pharmacological fMRI Study
- (2011) Matthijs G. Bossong et al. JOURNAL OF COGNITIVE NEUROSCIENCE
- Paranoid Schizophrenia is Characterized by Increased CB1 Receptor Binding in the Dorsolateral Prefrontal Cortex
- (2011) Victoria S Dalton et al. NEUROPSYCHOPHARMACOLOGY
- Modulation of Auditory and Visual Processing by Delta-9-Tetrahydrocannabinol and Cannabidiol: an fMRI Study
- (2011) Toby T Winton-Brown et al. NEUROPSYCHOPHARMACOLOGY
- Glutamate in Schizophrenia: A Focused Review and Meta-Analysis of 1H-MRS Studies
- (2011) Anouk Marsman et al. SCHIZOPHRENIA BULLETIN
- Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia
- (2011) Daniel J. Lodge et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Altered Relationship Between Hippocampal Glutamate Levels and Striatal Dopamine Function in Subjects at Ultra High Risk of Psychosis
- (2010) James M. Stone et al. BIOLOGICAL PSYCHIATRY
- Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study
- (2010) Celia J. A. Morgan et al. BRITISH JOURNAL OF PSYCHIATRY
- Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol
- (2009) Sagnik Bhattacharyya et al. ARCHIVES OF GENERAL PSYCHIATRY
- Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
- (2009) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
- Memory and the NMDA Receptors
- (2009) Fei Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS)
- (2008) Shin'Ya Tayoshi et al. SCHIZOPHRENIA RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started